Atlas Trials

Safety of ALK Ragweed Tablet

Clinical trial NCT00330083 · COMPLETED

Trial details

NCT number
NCT00330083
Sponsor
ALK-Abelló A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Allergy
Start date
2006-05-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.